Volume 13, Number 3—March 2007
Dispatch
Clostridium difficile–associated Disease in New Jersey Hospitals, 2000–20041
Esther T. Tan*†2
, Corwin A. Robertson*, Shereen Brynildsen*, Eddy Bresnitz*, Christina Tan*, and Clifford McDonald†
, Corwin A. Robertson*, Shereen Brynildsen*, Eddy Bresnitz*, Christina Tan*, and Clifford McDonald†
Table 2
Clostridium difficile surveillance activities conducted by hospitals, New Jersey, 2000–2004
| Surveillance activities | No. (%) hospitals |
|---|---|
| Monitors C. difficile–positive laboratory results | 55 (95) |
| Makes a distinction between community- and healthcare-acquired C. difficile cases | 44 (76) |
| Uses a standard C. difficile case definition for surveillance | 35 (60) |
| Monitors clinical outcome of patients with C. difficile infection | 28 (48) |
| Physicians notify infection-control professional of C. difficile diagnoses | 18 (31) |
1Presented in part at the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Chicago, Illinois, USA, March 20, 2006.
2Current affiliation: United Nations, New York, New York, USA
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.